With European leaders rushing to ramp up defence spending, these funds and trusts could position you to benefit from the ...

A coterie of Mayne Pharma holders reckons US bidder Cosette's $600 million tilt does not reflect the upside of the improving Mayne business.

Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that the Tribunal ...